128 views4 min read
Algernon Pharmaceuticals CEO To Deliver Virtual Keynote Presentation on Company’s DMT Program at the International Microdose DMT Conference
VANCOUVER, British Columbia, Sept. 09, 2021 -- Algernon Pharmaceuticals Inc.Β (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the βCompanyβ or βAlgernonβ) a clinical stage pharmaceutical development company, is pleased to announce that its CEO Christopher J. Moreau will be delivering the Keynote Presentation at the Microdose Virtual 2021 βThe ... Read More...